Years of Experience: 20+
Specialties: Executive Management, Laboratory Services, Operational Efficiencies, Strategic Growth, Business Development, Process Improvement, Manufacturing, Global Sales, Product Marketing
Albert Berger was appointed the Chief Executive Officer at Confirm BioSciences in August 2019. Berger brings to the company over two decades of relevant extensive experience in the screening and lab services industries, including multiple successes leading growth transformations of businesses and driving acquisitions on favorable terms. Berger’s broad expertise spans the areas of business development, operational efficiencies, manufacturing, clinical laboratories and medical devices, and he has built strong foundations for several multi-million-dollar companies. Prior to joining Confirm BioSciences, Berger served as the vice president and general manager of Redwood Toxicology Laboratory, a division of Alere Toxicology until its acquisition by Abbott Laboratories in October 2017. Under Berger’s leadership, Redwood grew to become one of the largest drug testing laboratories in the world. Prior, Berger served as the company’s chief executive officer and president, where he played an instrumental role in leading its acquisition by Alere Inc. for $100 million in 2008. Berger received a Bachelor of Science in organizational communication from Arizona State University and obtained a Master of Business Administration from Saint Mary’s College of California.